Neurocrine Biosciences
NBIX
#1606
Rank
NZ$22.05 B
Marketcap
NZ$219.70
Share price
-1.36%
Change (1 day)
15.56%
Change (1 year)
Neurocrine Biosciences is an American biopharmaceutical company that develops treatments for neurological and endocrine-related diseases and disorders.

We have found no dividend yield history for this company